Physician profile
Gary J Kosc
NPI 1932105236
$1,658.81
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $424 · 2021: $501.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.94 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $188.34 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.72 | 2019-2021 | |
| Qol Medical, LLC | $81.96 | 2019-2021 | |
| Janssen Biotech, INC. | $73.69 | 2019-2021 | |
| Pfizer INC. | $63.34 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $57.46 | 2019-2021 | |
| Evoke Pharma, INC. | $54.72 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $44.83 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $42.40 | 2020-2021 | |
| Redhill Biopharma INC. | $41.60 | 2020-2021 | |
| Gilead Sciences, INC. | $24.25 | 2019-2021 | |
| Allergan, INC. | $23.54 | 2019 | |
| Vivus LLC | $19.83 | 2019 | |
| Shionogi INC | $16.69 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.47 | 2019 | |
| Ethicon US, LLC | $14.35 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.98 | 2019 | |
| Shire North American Group INC | $12.39 | 2019 | |
| Braintree Laboratories, INC. | $11.90 | 2021 | |
| Celgene Corporation | $11.41 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Kosc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.